19211043

Source:http://linkedlifedata.com/resource/pubmed/id/19211043

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003873, umls-concept:C0030705, umls-concept:C0087111, umls-concept:C0871261, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2911692
pubmed:issue	5
pubmed:dateCreated	2009-3-9
pubmed:abstractText	To identify the clinical factors predicting failure or a good clinical response in the cohort of RA patients entered in the Lombardy Rheumatology Network (LORHEN) registry after 3 years of treatment with anti-TNF agents.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101128967
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor, http://linkedlifedata.com/resource/pubmed/chemical/TNFR-Fc fusion protein, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha, http://linkedlifedata.com/resource/pubmed/chemical/adalimumab, http://linkedlifedata.com/resource/pubmed/chemical/infliximab
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1873-0183
pubmed:author	pubmed-author:AntivalleMarcoM, pubmed-author:AtzeniFabiolaF, pubmed-author:BazzaniChiaraC, pubmed-author:CaporaliRobertoR, pubmed-author:FavalliEnnio GiulioEG, pubmed-author:GorlaRobertoR, pubmed-author:MarchesoniAntonioA, pubmed-author:PallaviciniFrancesca BobbioFB, pubmed-author:Sarzi-PuttiniPiercarloP
pubmed:issnType	Electronic
pubmed:volume	8
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	431-7
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:19211043-Adolescent, pubmed-meshheading:19211043-Adult, pubmed-meshheading:19211043-Aged, pubmed-meshheading:19211043-Aged, 80 and over, pubmed-meshheading:19211043-Anti-Inflammatory Agents, pubmed-meshheading:19211043-Antibodies, Monoclonal, pubmed-meshheading:19211043-Antibodies, Monoclonal, Humanized, pubmed-meshheading:19211043-Arthritis, Rheumatoid, pubmed-meshheading:19211043-Female, pubmed-meshheading:19211043-Follow-Up Studies, pubmed-meshheading:19211043-Humans, pubmed-meshheading:19211043-Immunoglobulin G, pubmed-meshheading:19211043-Male, pubmed-meshheading:19211043-Middle Aged, pubmed-meshheading:19211043-Receptors, Tumor Necrosis Factor, pubmed-meshheading:19211043-Remission Induction, pubmed-meshheading:19211043-Risk Factors, pubmed-meshheading:19211043-Severity of Illness Index, pubmed-meshheading:19211043-Sex Factors, pubmed-meshheading:19211043-Treatment Outcome, pubmed-meshheading:19211043-Tumor Necrosis Factor-alpha
pubmed:year	2009
pubmed:articleTitle	Predicting response to anti-TNF treatment in rheumatoid arthritis patients.
pubmed:affiliation	Rheumatology Unit, L. Sacco University Hospital, Milan, Italy. atzenifabiola@hotmail.com
pubmed:publicationType	Journal Article